CONSEQUENCES OF ANTIBODY-BINDING INVITRO ON THE PHARMACOLOGICAL PROPERTIES OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX

被引：7

作者：

FEARS, R

FERRES, H

HIBBS, M

STANDRING, R

机构：

来源：

DRUGS | 1987年 / 33卷

关键词：

D O I：

10.2165/00003495-198700333-00008

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：64 / 68

页数：5

共 9 条

[1] THE FIBRIN PLATE METHOD FOR ESTIMATING FIBRINOLYTIC ACTIVITY [J].

ASTRUP, T ;

MULLERTZ, S .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1952, 40 (02) :346-351

[2]

BARLOW GH, 1975, RES COMMUNICATIONS C, V3, P465

[3]

COLLEN D, 1986, HERZ, V11, P9

[4] DEACYLATION STUDIES INVITRO ON ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX [J].

FERRES, H ;

HIBBS, M ;

SMITH, RAG .

DRUGS, 1987, 33 :80-82

[5] CLEARANCE OF HETEROLOGOUS PROTEIN FROM THE CIRCULATION OF NORMAL AND IMMUNIZED MAN [J].

FLETCHER, AP ;

ALKJAERSIG, N ;

SHERRY, S .

JOURNAL OF CLINICAL INVESTIGATION, 1958, 37 (09) :1306-1315

[6]

GOREVIC PD, 1985, METHODS ENZYMOLOGY, V116, P6

[7]

JAMES DCO, 1973, POSTGRADUATE MED J S, V59, P26

[8] CLINICAL FAILURE OF STREPTOKINASE DUE TO AN UNSUSPECTED HIGH TITER OF ANTISTREPTOKINASE ANTIBODY [J].

LEW, AS ;

NEER, T ;

RODRIGUEZ, L ;

GEFT, IL ;

SHAH, PK ;

GANZ, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 4 (01) :183-185

[9]

MORAN DM, 1984, THROMB HAEMOSTASIS, V52, P281

← 1 →